Additionally, a purinergic receptor (ADORA1) has been previously implicated in asthma susceptibility by genome wide association studies (GWAS) and by functional studies (17), thereby further supporting the potential for purinergic receptors as therapeutic targets for asthma. Here, P2RX4 is linked to asthma.